Deutsche Bank
EWTX icon

Deutsche Bank’s Edgewise Therapeutics EWTX Stock Holding History

Deutsche Bank’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.2M Buy
274,686
+29,691
+12% +$1.26M ﹤0.01% 969
2026
Q2 		$10M Buy
244,995
+23,127
+10% +$797K ﹤0.01% 1064
2026
Q1 		$6.99M Buy
221,868
+7,099
+3% +$205K ﹤0.01% 1166
2025
Q4 		$5.33M Buy
214,769
+59,873
+39% +$1.2M ﹤0.01% 1276
2025
Q3 		$2.51M Buy
154,896
+7,371
+5% +$105K ﹤0.01% 1647
2025
Q2 		$1.93M Sell
147,525
-228,535
-61% -$3.3M ﹤0.01% 1728
2025
Q1 		$8.27M Buy
376,060
+100,223
+36% +$2.63M ﹤0.01% 1060
2024
Q4 		$7.36M Buy
275,837
+57,955
+27% +$1.85M ﹤0.01% 1146
2024
Q3 		$5.82M Buy
217,882
+186,768
+600% +$3.72M ﹤0.01% 1222
2024
Q2 		$560K Buy
31,114
+5,840
+23% +$102K ﹤0.01% 2278
2024
Q1 		$461K Buy
25,274
+4,864
+24% +$77.3K ﹤0.01% 2397
2023
Q4 		$223K Sell
20,410
-687
-3% -$4.82K ﹤0.01% 2813
2023
Q3 		$121K Buy
21,097
+3,177
+18% +$21.6K ﹤0.01% 3067
2023
Q2 		$139K Sell
17,920
-5,677
-24% -$47.9K ﹤0.01% 3091
2023
Q1 		$157K Buy
23,597
+6,960
+42% +$64.5K ﹤0.01% 3116
2022
Q4 		$149K Buy
16,637
+4,573
+38% +$42.9K ﹤0.01% 3119
2022
Q3 		$119K Sell
12,064
-1,991
-14% -$20.1K ﹤0.01% 3229
2022
Q2 		$112K Sell
14,055
-7,941
-36% -$60K ﹤0.01% 3473
2022
Q1 		$214K Sell
21,996
-2,498
-10% -$32.2K ﹤0.01% 3227
2021
Q4 		$374K Buy
24,494
+17,124
+232% +$308K ﹤0.01% 3011
2021
Q3 		$122K Buy
7,370
+25
+0.3% +$452 ﹤0.01% 3815
2021
Q2 		$156K Buy
+7,345
New +$201K ﹤0.01% 3925

Other funds holding EWTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Deutsche Bank's EWTX Position: Q3 2026 in Review

Deutsche Bank increased its Edgewise Therapeutics (EWTX) stake by 12% in Q3 2026, buying an estimated $1.26M and bringing the position to 274,686 shares worth $11.2M. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Deutsche Bank first reported a position in EWTX in Q2 2021 and has held it in 22 quarters since. 153 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Deutsche Bank held 274,686 shares of Edgewise Therapeutics worth $11.2M as of Q3 2026.
  • Deutsche Bank bought 29,691 Edgewise Therapeutics shares in Q3 2026, an estimated $1.26M.
  • Edgewise Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #969 holding.
  • Deutsche Bank first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 22 quarters since.
  • 153 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.